what was the first glp 1 drug Navigating -tides: Medication-Assisted Weight Loss on the Forefront Glucagon-like peptide-1 - Wikipedia
Description
According to WTWs 2024 survey, 52% of employers currently cover GLP-1s for weight loss, while 70% of non-covering employers say they might add coverage if prices drop
For patients taking oral semaglutide, which also requires administration on an empty stomach with a small amount of water at least 30 minutes before food or other medications, timing conflicts may arise

Patients with Parkinson's disease should not use GLP-1 receptor agonists outside of clinical trials or specific medical supervision for diabetes or obesity

[DOI] [PMC free article] [PubMed] [Google Scholar] 49.Squire P, Naude J, Zentner A, et al

Kidney function can be damaged

3 This has led to GLP-1 receptor agonists being licensed to promote weight loss in the setting of obesity
